title: Altered protein conformation and lower stability of the dystrophic transforming growth factor beta-induced protein mutants.
abstract: OBJECTIVE
  Transforming growth factor beta-induced protein (TGFBIp) is a widely expressed extracellular matrix protein that plays roles in cell adhesion and migration, differentiation, apoptosis, bone morphogenesis, and carcinogenesis. Mutations of TGFBIp have been linked to stromal corneal dystrophies, a group of protein conformational diseases characterized by abnormal protein aggregations in the cornea. However, the underlying pathogenic mechanism remains elusive due to a lack of insight into the molecular properties of the disease-causing mutants. In the current study, we applied spectroscopic tools to compare the conformation and protein stability of recombinant wild-type (WT) TGFBIp to two dystrophic mutants, R124C and R555W.
  
  
  METHODS
  A serum-free expression system was used to produce the recombinant TGFBIp proteins. Fluorescence and far-ultraviolet circular dichroism spectroscopies were used to compare WT and dystrophic mutants under various conditions.
  
  
  RESULTS
  Our results showed that dystrophic mutants were processed differentially by the expressing cells and produced different proteolytic fragment patterns by proteolysis. Intrinsic tryptophan fluorescence studies revealed moderate shifts in the emission maxima and increased quenching by iodide ion of mutant TGFBIp, suggesting a different conformation than WT protein. Denaturation experiments indicated a difference in protein stability between WT and mutant proteins. Under oxidizing conditions, the mutants produced higher 1-anilinonaphthalene-8-sulfonic acid and thioflavin T fluorescence signals than the WT, indicating increased protein unfolding and fibril formation, respectively. Finally, far-ultraviolet circular dichroism spectroscopy revealed that WT TGFBIp undergoes concentration-dependent conformational changes; similar experiments were not possible on mutant TGFBIp, which remained soluble only at low concentrations.
  
  
  CONCLUSIONS
  Our study provides new evidence for the pathogenic mechanism of dystrophic mutants. Although mutant TGFBIp has moderate but consistent structural perturbations, other factors such as oxidation or degradation may be required to cause the phenotypic abnormal aggregations.
authors.affiliation: Department of Ophthalmology and Visual Neurosciences, University of Minnesota Medical School, Minneapolis, MN, USA.
authors.forename: Heather L
authors.initials: HL
authors.lastname: Grothe
authors.forename: Morgan R
authors.initials: MR
authors.lastname: Little
authors.forename: Phayvanh P
authors.initials: PP
authors.lastname: Sjogren
authors.forename: Angela A
authors.initials: AA
authors.lastname: Chang
authors.forename: Elizabeth F
authors.initials: EF
authors.lastname: Nelson
authors.forename: Ching
authors.initials: C
authors.lastname: Yuan
mesh_terms: D000817:Anilino Naphthalenesulfonates / Q000378:metabolism; D052160:Benzothiazoles; D002942:Circular Dichroism; D003317:Corneal Dystrophies, Hereditary / Q000378:metabolism*; D016326:Extracellular Matrix Proteins / Q000737:chemistry* / Q000378:metabolism*; D006801:Humans; D050505:Mutant Proteins / Q000737:chemistry* / Q000378:metabolism*; D011487:Protein Conformation; D055550:Protein Stability; D059748:Proteolysis; D011994:Recombinant Proteins / Q000378:metabolism; D013050:Spectrometry, Fluorescence; D013844:Thiazoles / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000737:chemistry* / Q000378:metabolism*; D014364:Tryptophan / Q000378:metabolism; D000099222:betaIG-H3 Protein
chemical_list: D000817:Anilino Naphthalenesulfonates; D052160:Benzothiazoles; D016326:Extracellular Matrix Proteins; D050505:Mutant Proteins; D011994:Recombinant Proteins; D013844:Thiazoles; D016212:Transforming Growth Factor beta; D014364:Tryptophan; D000099222:betaIG-H3 Protein; C009462:thioflavin T; C027132:1-anilino-8-naphthalenesulfonate
references.citation: Mol Vis. 2007 Nov 07;13:2083-95
references.pmid: 18079684
references.citation: Nat Genet. 1997 Mar;15(3):247-51
references.pmid: 9054935
references.citation: Biochim Biophys Acta. 1997 Mar 1;1355(3):303-14
references.pmid: 9061001
references.citation: J Invest Dermatol. 2008 Apr;128(4):808-15
references.pmid: 17943184
references.citation: J Mol Biol. 2004 Sep 24;342(4):1305-24
references.pmid: 15351653
references.citation: J Biol Chem. 2000 Oct 6;275(40):30907-15
references.pmid: 10906123
references.citation: Oncogene. 2003 Apr 3;22(13):2045-53
references.pmid: 12673209
references.citation: J Mol Biol. 2011 May 6;408(3):503-13
references.pmid: 21371477
references.citation: Graefes Arch Clin Exp Ophthalmol. 2006 Jun;244(6):725-31
references.pmid: 16331487
references.citation: FEBS Lett. 2007 Jan 23;581(2):241-7
references.pmid: 17207483
references.citation: Exp Eye Res. 2012 Mar;96(1):163-70
references.pmid: 22155582
references.citation: J Biol Chem. 2011 Feb 18;286(7):4951-8
references.pmid: 21135107
references.citation: J Biochem. 2005 May;137(5):643-52
references.pmid: 15944418
references.citation: Cancer Cell. 2007 Dec;12(6):514-27
references.pmid: 18068629
references.citation: Biopolymers. 1972;11(6):1149-71
references.pmid: 5038705
references.citation: Biochim Biophys Acta. 1981 Mar 27;668(1):193-6
references.pmid: 7236706
references.citation: Invest Ophthalmol Vis Sci. 2003 Jul;44(7):2973-9
references.pmid: 12824240
references.citation: Biochemistry. 2004 Dec 28;43(51):16374-84
references.pmid: 15610032
references.citation: Front Biosci. 2003 May 01;8:d687-713
references.pmid: 12700042
references.citation: Biophys J. 2007 Sep 15;93(6):2170-7
references.pmid: 17513371
references.citation: J Am Chem Soc. 1971 Dec 29;93(26):7297-304
references.pmid: 4331380
references.citation: Invest Ophthalmol Vis Sci. 2002 Mar;43(3):656-61
references.pmid: 11867580
references.citation: Genes Dev. 2008 Feb 1;22(3):308-21
references.pmid: 18245446
references.citation: Biochemistry. 2006 Oct 3;45(39):11992-2002
references.pmid: 17002298
references.citation: Mol Vis. 2009 Dec 08;15:2617-26
references.pmid: 20011632
references.citation: DNA Cell Biol. 1992 Sep;11(7):511-22
references.pmid: 1388724
references.citation: Biophys J. 2001 Dec;81(6):3456-71
references.pmid: 11721007
references.citation: J Biol Chem. 2000 Apr 14;275(15):11465-9
references.pmid: 10753964
references.citation: DNA Cell Biol. 1994 Jun;13(6):571-84
references.pmid: 8024701
references.citation: Eur J Biochem. 2002 Jul;269(14):3362-71
references.pmid: 12135474
references.citation: Int J Oncol. 2008 Jan;32(1):235-40
references.pmid: 18097563
references.citation: Biochemistry. 1983 Mar 29;22(7):1533-9
references.pmid: 6342663
references.citation: Eur J Biochem. 2002 Nov;269(21):5149-56
references.pmid: 12392546
references.citation: Biochemistry. 1978 Nov 14;17(23):4951-4
references.pmid: 82446